MEDARTIS BUYConfirmation of the expanding wedge reversal with partial rise and break out with confirmation of the reversal structure.
Target is the IPO price
BIO
0.32 EUR
666.11 K EUR
228.14 M EUR
12.98 M
About MEDARTIS N
Sector
Industry
CEO
Matthias Schupp
Website
Headquarters
Basel
Founded
1997
ISIN
CH0386200239
FIGI
BBG00KD9X399
Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. It operates through the following geographical segments: EMEA, US, APAC, and LATAM. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.
LET INSPIRE FROM SPECULATIVE MOUVEMENTJust looked at IPO in switzerland this year. After a speedy scroll I was captured by two projects. Medartis and Sensirion.
Sensirion just mooned and if I had a little more time for stock market it was a clear buy for me.
Now let analyse Medartis.
IPO are tricky. There are differents movement aft
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange MEDARTIS HLDG AG SF-,20 stocks are traded under the ticker 1RU.
We've gathered analysts' opinions on MEDARTIS HLDG AG SF-,20 future price: according to them, 1RU price has a max estimate of 91.22 EUR and a min estimate of 91.22 EUR. Watch 1RU chart and read a more detailed MEDARTIS HLDG AG SF-,20 stock forecast: see what analysts think of MEDARTIS HLDG AG SF-,20 and suggest that you do with its stocks.
Yes, you can track MEDARTIS HLDG AG SF-,20 financials in yearly and quarterly reports right on TradingView.
MEDARTIS HLDG AG SF-,20 revenue for the last half-year amounts to 115.79 M EUR, despite the estimated figure of 118.64 M EUR. In the next half-year revenue is expected to reach 127.60 M EUR.
1RU net income for the last half-year is 2.66 M EUR, while the previous report showed 1.58 M EUR of net income which accounts for 68.72% change. Track more MEDARTIS HLDG AG SF-,20 financial stats to get the full picture.
No, 1RU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 29, 2024, the company has 876.00 employees. See our rating of the largest employees — is MEDARTIS HLDG AG SF-,20 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDARTIS HLDG AG SF-,20 EBITDA is 26.93 M EUR, and current EBITDA margin is 15.30%. See more stats in MEDARTIS HLDG AG SF-,20 financial statements.
Like other stocks, 1RU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDARTIS HLDG AG SF-,20 stock right from TradingView charts — choose your broker and connect to your account.